A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Clinical trial NCT05954312 · RECRUITING
Trial details
- NCT number
- NCT05954312
- Sponsor
- Vividion Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2030-08-31
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.